Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Let’s see if April can continue the trend of a growing amount of large raises. The company uses machine-generated content and AI to push marketing initiatives.

Biotech 103

Biotech Artificial Intelligence Artificial Inteligence Energy 103

Crunchbase News

MAY 2, 2024

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets. Let’s take a look.

Biotech 110

Biotech Generative AI Blockchain Energy 110

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 103

Biotech Generative AI Artificial Intelligence Artificial Inteligence 103

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

Perficient

MAY 21, 2024

An inefficient system wastes time and resources, can diminish morale, and ultimately hinders efforts to bring life-saving drugs to market.

Pharmaceuticals 52

Pharmaceuticals Artificial Inteligence Data Systems Review 52

Crunchbase News

FEBRUARY 15, 2024

The venture market was down 38% last year as investors continued to reel back their funding with money becoming more expensive and liquidity options drying up. With its cash-intensive research and long product-to-market lead time, it usually is not attractive to investors in a down market where cash is king.

Biotech 93

Biotech Artificial Intelligence Artificial Inteligence Energy 93

TechCrunch

SEPTEMBER 8, 2022

The startup is building a platform using synthetic DNA to store digital data, and has teamed up with storage vendor Seagate Technology for a research collaboration to advance its automated DNA storage and computation platform. Catalog , a Boston-based startup, has come up with a novel way of solving the problem.

Storage 206

Storage Artificial Inteligence Data Chemicals 206

TechCrunch

JANUARY 25, 2022

The Tunisian startup, headquartered in London with offices in Paris, Tunis, Lagos, Dubai and Cape Town, uses advanced machine learning techniques to bring AI to applications within an enterprise environment. But if technology has taught us anything, location doesn’t pose a barrier in getting global customers.

Enterprise 246

Enterprise Artificial Inteligence Machine Learning Transportation 246

TechCrunch

OCTOBER 6, 2022

France could become a leading market when it comes to sustainability-focused and impact startups due to local and European regulation, innovation and talent looking for opportunities in this ecosystem. But impact companies could still benefit from new processes, better network effects and more ambition in general.

Sustainability 188

Sustainability Programming Technical Review Biotech 188

Crunchbase News

APRIL 4, 2024

Table of Contents Healthcare and AI lead Seed Early stage grew Late-stage pullback IPO markets pop Methodology Glossary of funding terms Healthcare and AI lead AI continued to stand out as a leading sector for investment in the first quarter. The industry that raised the most amount of funding was healthcare and biotech.

Artificial Inteligence 124

Artificial Inteligence Healthcare Biotech Report 124

Crunchbase News

MAY 6, 2024

This has been particularly true for companies that took the SPAC route to public markets around the peak of the last boom. In response, a growing number are choosing to exit public markets and try their luck once again as private companies. After debuting on Nasdaq in 2021 at a $2.1 It didn’t go well.

Biotech 107

Biotech Case Study Marketing Study 107

Crunchbase News

FEBRUARY 7, 2024

While it’s too early to say venture funding will again increase in the sector this year, it is evident investors see the potential in both quantum technology and its ability to produce big financial returns. Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generative AI startup.

Energy 76

Energy Biotech Artificial Intelligence Artificial Inteligence 76

TechCrunch

MARCH 16, 2023

A new story, also by Ivan , reports that Apple is reportedly experimenting with language-generating AI so that Siri can better understand queries. Staying power : 5 strategies for biotech startups to outlast a market downturn , as advised by James Coates. Christine has more. Alex found some bullish news for software companies.

Banking 249

Banking Biotech Artificial Intelligence Artificial Inteligence 249

Crunchbase News

APRIL 8, 2024

On the exit front, meanwhile, Q1 brought some renewed excitement to the moribund IPO market with well-received debuts of Reddit and Astera Labs. Below we take a look at both investment and exit activity in more detail, breaking down totals by stage, looking at significant rounds, and tallying up largest M&A and public market exits.

Biotech 118

Biotech Artificial Intelligence Artificial Inteligence Quality Assurance 118

TechCrunch

SEPTEMBER 28, 2021

Lifebit says it has a patented technology for federating the data around genomic data, allowing researchers to get more insights while keeping the data secure. In an increasingly hot biotech market, protecting IP is key. Privacy issues are regularly raised around genomic data.

Biotech 248

Biotech Data Government Research 248

Crunchbase News

JANUARY 8, 2024

Table of contents Adieu, Q4 Late stage and technology growth Early stage Seed stage Exits M&A IPOs The big picture Methodology Glossary of funding terms Adieu, Q4 The fourth quarter of 2023 was particularly weak in comparison to recent prior quarters. For the fourth quarter, the largest early-stage rounds hailed from the biotech space.

Biotech 94

Biotech Generative AI Insurance Artificial Intelligence 94

Crunchbase News

MAY 7, 2024

The slowdown in venture funding has continued despite the AI technology wave that has washed over startups in the past few years. Large fundings were also raised by several deeptech and energy sustainability companies: electric vehicle developer Hozon ; solar provider Pine Gate Renewables ; and quantum computing company PsiQuantum.

Biotech 117

Biotech Generative AI Report Healthcare 117

TechCrunch

SEPTEMBER 14, 2021

Other fungicides on the market today require seven days before re-entry and pre-harvest, Uknes explained. His firm has an impact fund focused on the future of food and began investing in alternative proteins in 2016 before expanding that to delivery systems in agriculture technology, he said.

Technical Review 235

Technical Review Technology Chemicals Pharmaceuticals 235

TechCrunch

NOVEMBER 18, 2021

Therapeutic proteins, particularly monoclonal antibodies, are making up a bigger and bigger share of the drug market. Generate Biomedicines is focused on all protein modalities, but they have initially focused on developing antibodies, which Nally says make up about 60% of the protein-based biotherapeutics market. .

Artificial Inteligence 211

Artificial Inteligence Artificial Intelligence Machine Learning Report 211

Crunchbase News

FEBRUARY 16, 2024

Hundreds of professional futurists now work in government, academia and other sectors, analyzing demographic, technological and climatic trends to envision what life will look like years from now. AI-enabled healthcare There’s a lot of funding for nascent companies at the intersection of artificial intelligence and healthcare.

Construction 111

Construction Artificial Intelligence Artificial Inteligence Generative AI 111

TechCrunch

NOVEMBER 23, 2022

compared to the same time last year, it’s even more important for emerging technologies to present more than promises. The influx of artificial intelligence in healthcare is exciting but often met with skepticism from the public, and rightfully so. The large U.S. FDA breakthrough device designation.

How To 228

How To Healthcare Artificial Intelligence Artificial Inteligence 228

Crunchbase News

FEBRUARY 9, 2024

there were a good number of other large deals as well. That included more than $200 million for a security company and lots of big biotech raises. Neurona Therapeutics , $120M, biotech: San Francisco-based Neurona Therapeutics was the big biotch winner this week. billion valuation. Founded in 2013, the company has raised $261.5

Biotech 77

Biotech Games Healthcare Generative AI 77

Crunchbase News

FEBRUARY 8, 2024

Last week AI private market investors likely rejoiced when it was reported data center startup Astera Labs was preparing for a potential March initial public offering. When Astera raised its massive round in 2022, the market for funding for U.S.-based Also, not every chip designer startup is focused on the AI market.

Artificial Intelligence 83

Artificial Intelligence Artificial Inteligence Software Review Systems Review 83

TechCrunch

JANUARY 31, 2023

“InstaDeep happened to be quite different from other companies in our pipeline as they were actually into deep tech versus applying technology to a certain sector, where basically, you become an operator in that sector. They were developing specific technology that could impact many sectors,” noted Jilani on InstaDeep’s pioneering tech.

Technical Review 248

Technical Review Biotech Systems Review Software Review 248

TechCrunch

DECEMBER 17, 2022

Artificial intelligence is having (another) moment — which means scrappy innovation is getting some deserved, if not buzzy, attention. 6 investors discuss why AI is more than just a buzzword in biotech. 6 investors discuss why AI is more than just a buzzword in biotech. The impact of hype with Clubhouse’s Paul Davison.

Technical Review 246

Technical Review Open Source ChatGPT Biotech 246

Existek

SEPTEMBER 28, 2023

With the major progress in all sub-domains of artificial intelligence, the demand for AI developers has tremendously increased. AI-related skills are highly valued in the market and adopted in various industries. Considering the rapid pace of technological advancements, we can’t underestimate the maturation of AI.

Artificial Inteligence 52

Artificial Inteligence Development How To Artificial Intelligence 52

CIO

NOVEMBER 30, 2022

Encouraging technologists, often introverts who have spent their careers mastering complex skills, to deepen their understanding of marketing, commercial operations, supply chain, and finance is a slow march. Carissa Rollins, who became the CIO of Illumina in April of this year, strongly believes in the capabilities management model.

Biotech 218

Biotech Strategy Leadership Transportation 218

TechCrunch

FEBRUARY 22, 2022

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. and wider European markets. the discovery and cultivation of purpose-built microbes).

Hardware 216

Hardware Biotech Technical Review Systems Review 216

Crunchbase News

FEBRUARY 20, 2024

The year-old company is building a large language model trained on local Indian languages as well as English. Clean energy Guangdong, China-based Chunqing Technology , developer of electric vehicles powered by alcohol and hydrogen, raised $100 million in its first funding. billion in this recent funding round.

Company 88

Company Artificial Inteligence Transportation Sport 88

TechCrunch

SEPTEMBER 14, 2022

The global cultured meat market is poised to reach half a billion dollars by 2030; however, this kind of technology is still very much in the R&D phase for a lot of companies that have emerged over the past five years. The company aims to do for biology what Henry Ford did for automobiles at the turn of the 20th century.

Culture 233

Culture Pharmaceuticals Machine Learning Artificial Inteligence 233

Crunchbase News

JANUARY 12, 2024

billion invested in financial services in 2022, and even more dramatically from the $143 billion invested in the sector in the peak market of 2021. Funding in 2023 to health care startups, including biotech companies, also topped financial services, as it has in prior years. That’s down more than 50% year over year from the $89.5

Fintech 111

Fintech Biotech Insurance Wireless 111

TechCrunch

OCTOBER 18, 2021

The basic idea makes perfect sense: build a better small-scale simulation of a human body and use it to gather data that a machine learning system can easily interpret. ” Avalo uses machine learning to accelerate the adaptation of crops to climate change. The round was led by “Dr.

Testing 244

Testing Artificial Inteligence Development Machine Learning 244

TechCrunch

MARCH 9, 2021

That’s notable, considering that Flagship incubated 11-year-old Moderna, which currently boasts a $50 billion market cap thanks in large part its coronavirus vaccine. DB: I believe what we’ve done over the last two years is build an incredibly strong technology basis and foundation [for] transformation.

Company 255

Company Machine Learning Artificial Inteligence Groups 255

Pandora's Brain

AUGUST 11, 2023

Kindred Capital Venture capital is the lifeblood of technology startups, including young companies deploying advanced AI. Its preferred sectors are ‘techbio’ (by which he means tech-focused biotech businesses), software (especially software as a service, or SAAS), energy and fintech.

Generative AI 52

Generative AI Artificial Inteligence Biotech Pharmaceuticals 52

TechCrunch

OCTOBER 18, 2022

The port combines chemo-port efficacy with sensor technology to measure and remotely monitor early onset of complications by reporting and tracking patient response over the course of their treatment. The company’s Series A investment round, which Skinner says will consist of $10 million, will occur in 2023.

Pharmaceuticals 228

Pharmaceuticals Testing Exercises Trends 228

TechCrunch

JANUARY 20, 2021

Still, Embryonics is interesting for its potential to shake up a big market that’s been stuck for decades and continues to grow only because of external trends, like millennial women who are putting off having children owing to economic concerns. billion in 2019 to nearly double that number in the next five years by some estimates.

Weak Development Team 272

Weak Development Team Training Study Analysis 272

TechCrunch

JANUARY 16, 2021

Some people are more excited by emerging areas like artificial intelligence, which has been a focus of the country’s military for years, and like cybersecurity is now producing many fresh teams of founders. This a great example of company that is disrupting a traditional market. What’s your latest, most exciting investment?

Technical Review 354

Technical Review Software Review Trends Systems Review 354